Uncultured, autologous, adipose-derived regenerative cells (UA-ADRCs) therapy(National Scientific Medical Center, Kazakhstan)

N/A

Report date: 2024/11/27 20:00:40

Base Information

Drug NameUncultured, autologous, adipose-derived regenerative cells (UA-ADRCs) therapy(National Scientific Medical Center, Kazakhstan)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Regenerative cell therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy > Donor > Autologous
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsPostoperative ComplicationsVentricular Dysfunction, LeftCoronary Artery Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryKazakhstan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Scientific Medical Center, Kazakhstan
China Registration ClassN/A

Develop Information

Active CompaniesNational Scientific Medical Center, Kazakhstan
Inactive CompaniesN/A
Active IndicationsPostoperative ComplicationsVentricular Dysfunction, LeftCoronary Artery Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A